Encephalopathy News and Research

RSS

New 15-minute scan could help diagnose brain damage in babies up to two years old

A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods. In a study of over 200 babies at seven hospitals across the UK and the USA, researchers found the brain scan, called magnetic resonance spectroscopy, predicted damage with 98 percent accuracy.

15 Nov 2018

Researchers identify genetic variation that may influence severity of CTE disease

Researchers have identified a genetic variation that may influence chronic traumatic encephalopathy disease severity.

5 Nov 2018

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians.

26 Oct 2018

Mad Cow disease found on Aberdeenshire farm

Scotland has confirmed its first case of Mad Cow disease or Bovine Spongiform Encephalopathy (BSE) since 2018 on a cattle farm. The case was confirmed after a cow died.

19 Oct 2018

Thalamus controls development of normal sleep and waking states, study finds

Consciousness requires continuous, internally generated activity in the brain. The modulation of this activity is the basis of the electroencephalogram (EEG) and of generation of sleep, dreams, and perception.

12 Oct 2018

Columbia scientist and collaborators receive $11.3 million to find new targets against brain disease

Anthony Fitzpatrick, PhD, a Principal Investigator at Columbia's Zuckerman Institute and Columbia University Irving Medical Center, together with scientists from the Mayo Clinic and Boston Children's Hospital, has been awarded $11.3 million to map the three-dimensional structures of protein tangles that accumulate in the human brain.

11 Oct 2018

Study sheds light on molecular mechanisms underlying progression of prion diseases

A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

21 Sep 2018

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Routine oral care to treat gum disease may play a role in reducing inflammation and toxins in the blood and improving cognitive function in people with liver cirrhosis.

29 Aug 2018

Scientists pinpoint the cause of a rare childhood seizure disorder

Scientists have developed a set of computational tools that pinpoint the cause of Early Infantile Epileptic Encephalopathy (EIEE), a rare childhood disorder.

13 Aug 2018

Study: Women's brains more vulnerable than men's to injury from soccer heading

Women's brains are much more vulnerable than men's to injury from repeated soccer heading, according to a new study by researchers at Albert Einstein College of Medicine, part of Montefiore.

31 Jul 2018

Military personnel with head trauma and football players with suspected CTE show similar brain changes

In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.

18 Jul 2018

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

An estimated 3.5 million people in the United States have chronic hepatitis C (HCV), according to the Centers for Disease Control and Prevention.

18 Jun 2018

Sleep disorders appear to be first sign of serious neurological diseases

Sleep disorders are often the first sign of serious neurological diseases. Neurologists should inquire extensively about the quality of their patients' sleep.

18 Jun 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

Knopp Biosciences LLC today announced the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes met its co-primary endpoints.

10 May 2018

Advances in genetic testing give new insights to parents of children with epileptic encephalopathy

Advances in genetic testing offer new insights to parents who have a child with a rare but serious form of epilepsy, epileptic encephalopathy (EE), found in one of about every 2,000 births and characterized by developmental disabilities as well as horrible seizures.

26 Apr 2018

Study finds no evidence of chronic wasting disease transmissibility in macaques

Chronic wasting disease did not cross the species barrier to infect cynomolgus macaque monkeys during a lengthy investigation by National Institutes of Health scientists exploring risks to humans.

26 Apr 2018

Researchers discover blood biomarkers that may help detect, confirm mild traumatic brain injury

Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained a mild traumatic brain injury (mTBI), commonly known as a concussion.

20 Apr 2018

Single FMT enema produces sustained and significant improvements in cognitive function

A single treatment using an optimized, targeted form of faecal microbiota transplantation (FMT) produces sustained clinical and cognitive improvements, according to the results of a long-term follow-up of patients with liver cirrhosis and hepatic encephalopathy (HE) who had participated in a short-term study.

16 Apr 2018

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.

7 Apr 2018